Tapewire

Nasdaq · USD

SCYX

SCYNEXIS INC

Export transactions ↓
Tapewire entity
7194
SEC CIK
0001178253
Parsed reports
196

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202610
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 06, 2020 Filed Jul 8, 2020 20:11 UTC GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-20-041739 · doc4.xml · derivative · entry 1

HASTINGS DAVID C · CIK 0001237401 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2030-07-05

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:10 UTC
HANHAM ANNDirector
GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-20-041737 · doc4.xml · derivative · entry 1

HANHAM ANN · CIK 0001286338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2030-07-05

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:09 UTC GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-20-041735 · doc4.xml · derivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2030-07-05

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:07 UTC GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-20-041731 · doc4.xml · derivative · entry 1

ANIDO ARMANDO · CIK 0001219866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2030-07-05

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
July 06, 2020 Filed Mar 31, 2021 20:05 UTC Amendment GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-21-023766 · doc4a.xml · derivative · entry 1

Tinmouth Brian Philippe · CIK 0001797160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2030-07-05

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
July 06, 2020 Filed Mar 31, 2021 20:04 UTC Amendment GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-21-023764 · doc4a.xml · derivative · entry 1

Macdonald Guy · CIK 0001296998 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2030-07-05

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
July 06, 2020 Filed Mar 31, 2021 20:04 UTC Amendment GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-21-023761 · doc4a.xml · derivative · entry 1

HASTINGS DAVID C · CIK 0001237401 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2030-07-05

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant; provided, that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
July 06, 2020 Filed Mar 31, 2021 20:03 UTC Amendment
HANHAM ANNDirector
GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-21-023759 · doc4a.xml · derivative · entry 1

HANHAM ANN · CIK 0001286338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2030-07-05

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
July 06, 2020 Filed Mar 31, 2021 20:02 UTC Amendment GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-21-023758 · doc4a.xml · derivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2030-07-05

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
July 06, 2020 Filed Mar 31, 2021 20:00 UTC Amendment GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-21-023757 · doc4a.xml · derivative · entry 1

ANIDO ARMANDO · CIK 0001219866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2030-07-05

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
February 15, 2020 Filed Dec 5, 2020 02:00 UTC
Sukenick ScottGeneral Counsel
Tax withholdingCommon Stock 783 $9.80 $7,673.40
Disclosure

SEC source: 0001209191-20-061879 · doc4.xml · nonDerivative · entry 1

Sukenick Scott · CIK 0001722886 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,912

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations that arose in connection with a vesting event from a restricted stock unit award.

Read SEC document
February 15, 2020 Filed Dec 5, 2020 01:59 UTC
Francois EricChief Financial Officer
Tax withholdingCommon Stock 979 $9.80 $9,594.20
Disclosure

SEC source: 0001209191-20-061878 · doc4.xml · nonDerivative · entry 1

Francois Eric · CIK 0001656125 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,412

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations that arose in connection with a vesting event from a restricted stock unit award.

Read SEC document
February 15, 2020 Filed Dec 5, 2020 01:57 UTC
Angulo Gonzalez DavidChief Medical Officer
Tax withholdingCommon Stock 1,175 $9.80 $11,515.00
Disclosure

SEC source: 0001209191-20-061876 · doc4.xml · nonDerivative · entry 1

Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,303

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations that arose in connection with a vesting event from a restricted stock unit award.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:04 UTC
Francois EricChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 375,000 $0.00 Strike: $0.86 $0.00
Disclosure

SEC source: 0001209191-20-006273 · doc4.xml · derivative · entry 1

Francois Eric · CIK 0001656125 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Common Stock · 375,000 shares

Expires 2030-01-30

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:05 UTC
Sukenick ScottGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 250,000 $0.00 Strike: $0.86 $0.00
Disclosure

SEC source: 0001209191-20-006274 · doc4.xml · derivative · entry 1

Sukenick Scott · CIK 0001722886 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2030-01-30

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:03 UTC
Angulo Gonzalez DavidChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 450,000 $0.00 Strike: $0.86 $0.00
Disclosure

SEC source: 0001209191-20-006269 · doc4.xml · derivative · entry 1

Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2030-01-30

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:02 UTC
Taglietti MarcoDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 900,000 $0.00 Strike: $0.86 $0.00
Disclosure

SEC source: 0001209191-20-006266 · doc4.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 900,000

Underlying: Common Stock · 900,000 shares

Expires 2030-01-30

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 22:14 UTC GrantStock Option (right to buy) · Derivative 70,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-19-060913 · doc4.xml · derivative · entry 1

Tinmouth Brian Philippe · CIK 0001797160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2029-12-13

F1 · derivative.exercise_date: One third of the shares subject to this option vest on the one year anniversary of the grant date, and 1/36 of the shares subject to the option vest on each of the next 24 months thereafter.

Read SEC document
December 12, 2019 Filed Dec 16, 2019 20:10 UTC
Taglietti MarcoDirector · Chief Executive Officer
PurchaseCommon Stock Warrant (right to buy) · Derivative 166,667 Not disclosed Strike: $1.10 Not disclosed
Disclosure

SEC source: 0001209191-19-060615 · doc4.xml · derivative · entry 2

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,667

Underlying: Common Stock · 166,667 shares

Expires not disclosed

F1 · price: Reflects the purchase on December 12, 2019, of 166,667 shares of the issuer's common stock at a public offering price of $0.90 per share of common stock and accompanying warrant.

F2 · derivative.expiration_date: The warrant expires on the earlier of (i) such date that is six months after the issuer publicly announces the approval from the U.S. Food and Drug Administration for ibrexafungerp for the treatment of vulvovaginal candidiasis and (ii) June 12, 2023.

Read SEC document
December 12, 2019 Filed Dec 16, 2019 20:10 UTC
Taglietti MarcoDirector · Chief Executive Officer
PurchaseCommon Stock 166,667 $0.90 $150,000.30
Disclosure

SEC source: 0001209191-19-060615 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 693,682

F1 · price: Reflects the purchase on December 12, 2019, of 166,667 shares of the issuer's common stock at a public offering price of $0.90 per share of common stock and accompanying warrant.

Read SEC document
August 21, 2019 Filed Aug 22, 2019 12:22 UTC
Taglietti MarcoDirector · Chief Executive Officer
PurchaseCommon Stock 9,500 $1.11 $10,545.00
Disclosure

SEC source: 0001209191-19-047071 · doc4.xml · nonDerivative · entry 2

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 526,015

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.11 to $1.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 20, 2019 Filed Aug 22, 2019 12:22 UTC
Taglietti MarcoDirector · Chief Executive Officer
PurchaseCommon Stock 500 $1.11 $555.00
Disclosure

SEC source: 0001209191-19-047071 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 516,515

Read SEC document
August 15, 2019 Filed Aug 19, 2019 12:31 UTC
Taglietti MarcoDirector · Chief Executive Officer
PurchaseCommon Stock 10,015 $1.01 $10,115.15
Disclosure

SEC source: 0001209191-19-046455 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 516,015

Read SEC document
June 18, 2019 Filed Jun 20, 2019 17:35 UTC GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001209191-19-038198 · doc4.xml · derivative · entry 1

Macdonald Guy · CIK 0001296998 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2029-06-17

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 17:34 UTC GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001209191-19-038197 · doc4.xml · derivative · entry 1

HASTINGS DAVID C · CIK 0001237401 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2029-06-17

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 17:33 UTC
HANHAM ANNDirector
GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001209191-19-038196 · doc4.xml · derivative · entry 1

HANHAM ANN · CIK 0001286338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2029-06-17

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 17:32 UTC GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001209191-19-038195 · doc4.xml · derivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2029-06-17

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 17:31 UTC GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0001209191-19-038194 · doc4.xml · derivative · entry 1

ANIDO ARMANDO · CIK 0001219866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2029-06-17

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
April 17, 2019 Filed Apr 18, 2019 12:39 UTC
Taglietti MarcoDirector · Chief Executive Officer
PurchaseCommon Stock 25,000 $1.63 $40,750.00
Disclosure

SEC source: 0001209191-19-025201 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 506,000

Read SEC document
February 15, 2019 Filed Feb 19, 2019 21:54 UTC
Taglietti MarcoDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 700,000 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001209191-19-011129 · doc4.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 700,000

Underlying: Common Stock · 700,000 shares

Expires 2029-02-14

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 21:52 UTC
Francois EricChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001209191-19-011127 · doc4.xml · derivative · entry 2

Francois Eric · CIK 0001656125 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2029-02-14

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 21:52 UTC
Francois EricChief Financial Officer
GrantCommon Stock 125,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011127 · doc4.xml · nonDerivative · entry 1

Francois Eric · CIK 0001656125 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,917

F1 · shares: Represents restricted stock units that vest 25% per year over four years.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 21:53 UTC
Sukenick ScottGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001209191-19-011128 · doc4.xml · derivative · entry 2

Sukenick Scott · CIK 0001722886 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2029-02-14

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 21:53 UTC
Sukenick ScottGeneral Counsel
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011128 · doc4.xml · nonDerivative · entry 1

Sukenick Scott · CIK 0001722886 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,959

F1 · shares: Represents restricted stock units that vest 25% per year over four years.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 21:51 UTC
Angulo Gonzalez DavidChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001209191-19-011123 · doc4.xml · derivative · entry 2

Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2029-02-14

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 21:51 UTC
Angulo Gonzalez DavidChief Medical Officer
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011123 · doc4.xml · nonDerivative · entry 1

Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,790

F1 · shares: Represents restricted stock units that vest 25% per year over four years.

Read SEC document
January 21, 2019 Filed Jan 23, 2019 14:34 UTC GrantStock Option (right to buy) · Derivative 70,000 $0.00 Strike: $0.74 $0.00
Disclosure

SEC source: 0001209191-19-004901 · doc4.xml · derivative · entry 1

ANIDO ARMANDO · CIK 0001219866 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2029-01-21

F1 · derivative.exercise_date: One third of the shares subject to this option vest on the one year anniversary of the grant date, and 1/36 of the shares subject to the option vest on each of the next 24 months thereafter.

Read SEC document
January 10, 2019 Filed Jan 14, 2019 14:04 UTC
Taglietti MarcoDirector · Chief Executive Officer
PurchaseCommon Stock 25,000 $0.69 $17,250.00
Disclosure

SEC source: 0001209191-19-003517 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 480,000

Read SEC document
January 02, 2019 Filed Jan 4, 2019 13:10 UTC GrantStock Option (right to buy) · Derivative 22,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0001209191-19-001641 · doc4.xml · derivative · entry 1

Machado Patrick · CIK 0001311210 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2029-01-01

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 13:09 UTC GrantStock Option (right to buy) · Derivative 22,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0001209191-19-001640 · doc4.xml · derivative · entry 1

Macdonald Guy · CIK 0001296998 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2029-01-01

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 13:05 UTC GrantStock Option (right to buy) · Derivative 22,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0001209191-19-001637 · doc4.xml · derivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2029-01-01

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 13:06 UTC
HANHAM ANNDirector
GrantStock Option (right to buy) · Derivative 22,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0001209191-19-001638 · doc4.xml · derivative · entry 1

HANHAM ANN · CIK 0001286338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2029-01-01

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 13:08 UTC GrantStock Option (right to buy) · Derivative 22,500 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0001209191-19-001639 · doc4.xml · derivative · entry 1

HASTINGS DAVID C · CIK 0001237401 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2029-01-01

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.

Read SEC document
December 31, 2018 Filed Jan 2, 2019 16:28 UTC
Taglietti MarcoDirector · Chief Executive Officer
PurchaseCommon stock 25,000 $0.46 $11,500.00
Disclosure

SEC source: 0001209191-19-000039 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 455,000

Read SEC document
December 31, 2018 Filed Jan 2, 2019 16:28 UTC
Angulo Gonzalez DavidChief Medical Officer
PurchaseCommon stock 12,000 $0.50 $5,950.80
Disclosure

SEC source: 0001209191-19-000037 · doc4.xml · nonDerivative · entry 1

Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,790

Read SEC document
October 01, 2018 Filed Oct 3, 2018 18:53 UTC GrantStock option (right to buy) · Derivative 21,595 $0.79 Strike: $1.22 $17,060.05
Disclosure

SEC source: 0001209191-18-053681 · doc4.xml · derivative · entry 1

Macdonald Guy · CIK 0001296998 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,595

Underlying: Common Stock · 21,595 shares

Expires 2028-09-30

F1 · price: Stock option received by the Reporting Person pursuant to such Reporting Person's election to receive stock option in lieu of the Reporting Person's annual cash retainers (paid quarterly) under the Compensation Arrangement with Non-Employee Directors policy.

Read SEC document
September 06, 2018 Filed Sep 10, 2018 13:09 UTC
Angulo Gonzalez DavidChief Medical Officer
PurchaseCommon Stock 7,000 $1.27 $8,890.00
Disclosure

SEC source: 0001209191-18-050184 · doc4.xml · nonDerivative · entry 1

Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,790

Read SEC document
August 23, 2018 Filed Aug 27, 2018 12:29 UTC
Taglietti MarcoDirector · Chief Executive Officer
PurchaseCommon Stock 25,000 $1.29 $32,250.00
Disclosure

SEC source: 0001209191-18-048444 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 429,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.26 to $1.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 17:37 UTC GrantStock option (right to buy) · Derivative 15,589 $1.10 Strike: $1.69 $17,147.90
Disclosure

SEC source: 0001209191-18-040675 · doc4.xml · derivative · entry 1

Macdonald Guy · CIK 0001296998 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,589

Underlying: Common Stock · 15,589 shares

Expires 2028-07-01

F1 · price: Stock option received by the Reporting Person pursuant to such Reporting Person's election to receive stock option in lieu of the Reporting Person's annual cash retainers (paid quarterly) under the Compensation Arrangement with Non-Employee Directors policy.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 17:39 UTC GrantStock option (right to buy) · Derivative 9,217 $1.10 Strike: $1.69 $10,138.70
Disclosure

SEC source: 0001209191-18-040676 · doc4.xml · derivative · entry 1

McCourt Marion · CIK 0001663758 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,217

Underlying: Common Stock · 9,217 shares

Expires 2028-07-01

F1 · price: Stock option received by the Reporting Person pursuant to such Reporting Person's election to receive stock option in lieu of the Reporting Person's annual cash retainers (paid quarterly) under the Compensation Arrangement with Non-Employee Directors policy.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.